Objective:

The commentary identifies what is new in two recent evidence-based publications on lung ultrasound and explains the purpose and limits of their formal statements.

Approach:

• Diagnostic and quantitative use: The recommendations distinguish focused, pattern-based diagnosis from standardized, multi-zone quantification. Quantification covers aeration, congestion, pneumothorax volume, and pleural effusion.
• Three diagnostic tiers: The framework separates elementary signs, supplementary features that refine differential diagnosis, and clinical interpretation integrating ultrasound with the broader diagnostic picture.
• Clinical applications: The commentary reviews evidence in heart failure, dialysis, and critical-care assessment of aeration and congestion.

Key Findings:

• Evidence supporting lung ultrasound’s prognostic role is more robust than evidence supporting its use to guide treatment.
• In decompensated heart failure, B-line counts correlate with disease severity and predict rehospitalization and mortality at admission and discharge. This prognostic information is independent of ejection fraction and also applies to moderate-to-severe aortic stenosis, ST-elevation myocardial infarction, and cardiogenic shock.
• In chronic heart failure, monitoring B-lines can guide treatment; adjusting therapy according to B-line levels has been associated with reduced hospitalization for decompensation.
• In dialysis patients, sonographic congestion may be dissociated from signs and symptoms and predicts mortality and cardiac events. Robust evidence that ultrasound-guided adjustment of fluid removal improves survival is lacking.
• In critically ill patients, lung aeration scores track the effects of PEEP, recruitment maneuvers, and drugs and have prognostic value.
• Absence of selected elementary signs may make related conditions unlikely, but their presence alone does not establish a diagnosis.

Interpretation:

The recommendations emphasize that image acquisition, recognition of sonographic signs, and clinical interpretation are distinct steps. Ultrasound findings are a starting point for clinical reasoning and should not be considered sufficient in isolation.

Limitations:

• The provided article context ends mid-sentence during discussion of ventilatory-strategy personalization, so that section is incomplete.
• Aeration scores are coarse semi-quantitative measures, with methodological limitations and no linear progression across score classes.
• Evidence is limited for improving survival by adjusting dialysis fluid removal according to sonographic congestion.

Conclusion:

Lung ultrasound provides valuable diagnostic and prognostic information across several clinical settings, but its findings must be interpreted in context. The recommendations offer a framework for standardized examination and reporting; they do not replace clinical judgment or establish that ultrasound-guided treatment improves outcomes in every setting. Further evidence is needed to clarify how quantitative findings can best guide management.